Engineered Cells

APOE Knockout in HMC3 Cell Line (Human)

The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. [provided by RefSeq, Jun 2016]

Guides designed
3
Cuts canonical
Yes
Coding seq. cut
62%–75%
CCDS cut
24 of 24
Earliest exon cut
Exon 4
Off-target genes
None
Molecular function
amyloid-beta bindingsignaling receptor bindingstructural molecule activitylipid carrier activityprotein bindingphospholipid binding
Biological process
response to reactive oxygen speciesretinoid metabolic processnegative regulation of endothelial cell proliferationtriglyceride metabolic processlipid transportreceptor-mediated endocytosis
Cellular component
extracellular regionnucleuscytoplasmearly endosomemultivesicular bodyendoplasmic reticulum
Homo sapiens (Human)CVCL_II76

Transformed cell line · Sex unspecified · 8-10FW · future brain

APOE DepMap profile

No exact DepMap match for this line, so per-gene dependency/expression isn't available (only ~⅔ of lines are profiled).

XDel Knockout Cells Enable gene-edited knockout cell pools and clones - Guaranteed and Delivered in 4 Weeks (Pools) or 10 Weeks (Clones)
XDel is a cutting-edge CRISPR knockout technology designed to remove the guesswork from gene editing. By leveraging an innovative guide RNA design strategy, XDel delivers highly efficient, consistent, and reproducible gene knockouts—empowering researchers to accelerate their discoveries with confidence.